Офтальмохирургия. 2020; : 24-30
Сравнительная оценка суточных кривых ВГД у пациентов с осложненной катарактой на фоне псевдоэксфолиативного синдрома до и после факоэмульсификации с имплантацией ИОЛ
https://doi.org/10.25276/0235-4160-2020-3-24-30Аннотация
Цель. Проанализировать изменения суточных амплитуд внутри- глазного давления (ВГД) и тонометрических кривых у пациентов с осложненной катарактой на фоне псевдоэксфолиативного синдрома (ПЭС) до и после факоэмульсификации катаракты с имплантацией интраокулярной линзы (ФЭК+ИОЛ).
Материал и методы. Исследовано 154 глаза 154 пациентов с катарактой на фоне ПЭС, которых разделили на 3 группы: 1-я группа – с уровнем ВГД до операции (менее 21 мм рт.ст.) (n=55); 2-я группа – с ВГД 22–27 мм рт.ст. до операции (n=57); 3-я группа – с начальной первичной открытоугольной глаукомой (n=42). Исследовали амплитуды суточных колебаний ВГД и суточных кривых ВГД до и после проведения операции.
Результаты. До проведения ФЭК+ИОЛ амплитуда суточных ко- лебаний ВГД в 1-й группе составила 5,22±0,49 мм рт.ст., а в двух других 6,81±1,21 и 6,60±1,49 мм рт.ст. соответственно. После ФЭК+ИОЛ у пациентов 1-й группы было отмечено достоверное уменьшение амплитуды суточных колебаний ВГД на 1,27±0,93 мм рт.ст. (p<0,001); у пациентов 2-й группы – уменьшение амплитуды суточных колебаний ВГД на 2,34±1,26 мм рт.ст. (p<0,001). У пациентов 3-й группы было отмечено уменьшение амплитуды суточных колебаний ВГД на 1,15±1,14 мм рт.ст. (p<0,001). Наблюдалась нормализация суточных флуктуаций ВГД у большинства пациентов.
Вывод. Проведение ФЭК+ИОЛ у пациентов с катарактой и ПЭС позволяет нормализовать уровень ВГД, его амплитуду и тип суточной кривой.
Список литературы
1. Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007;114: 3. doi:10.1016/j.ophtha.2006.05.075
2. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Manifest E; Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121: 48–56. doi:10.1001/archopht.121.1.48
3. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 714–720. doi:10.1001/archopht.120.6.714
4. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130: 429–440. doi:10.1016/S0002-9394(00)00538-9
5. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134: 499–512. doi:10.1016/s0002-9394(02)01659-8
6. Kass MA, Heuer DK, Higginbotham EJ. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypertensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2000;120: 701–713. doi:10.1001/archopht.120.6.701
7. Lichter PR, Musch DC, Gillespie BW. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108: 1943–1953. doi:10.1016/s0161-6420(01)00873-9
8. Кrause U, Alanko HI Karna. Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol. 1988;184: 120–122. doi:10.1111/j.1755-3768.1988.tb02642.x
9. Schlötzer-Schrehardt UM, Naumann GOH. Ocular and systemic pseudoexfoliation syndrome. Am J of Ophthalmol. 2006;141: 921–937. doi:10.1016/j.ajo.2006.01.047
10. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45: 265–315. doi:10.1016/s0039-6257(00)00196-x
11. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22: 253–275.
12. Jeng S, Karger R, Hodge D, Burke J, Johnson D, Good M. The risk of glaucoma in pseudoexfoliation syndrome. J Glaucoma. 2007;16: 117–121. doi:10.1097/01.ijg.0000243470.13343.8b
13. Brengtsson B, Heiji A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2005;243: 513–518. doi:10.1007/s00417-004-1103-8
14. Altintaş O, Yüksel N, Karabaş VL, Qağlar Y. Diurnal intraocular pressure variation in pseudoexfoliation syndrome. Eur J Ophthalmol. 2004;14: 495–500.
15. Vesti E, Kivel ÄT. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19: 345–368. doi:10.1016/s1350-9462(99)00019-1
16. Prince AM, Ritch R. Clinical signs of exfoliations syndrome. Ophthalmology. 1986;93: 803–807. doi:10.1016/s0161-6420(86)33664-9
17. Kim KS, Kim JM, Park KH, Choi CY, Chang HR. The effect of cataract surgery on diurnal intraocular pressure fluctuation. J Glaucoma. 2009;18: 399–402. doi:10.1097/IJG.0b013e3181879e89
18. Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115: 182–185. doi:10.1001/archopht.1997.01100150184006
19. Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye (Lond). 2000;14: 73–77. doi:10.1038/eye.2000.16
20. David R, Zangwill L, Briscoe D, Dagan M, Yagev R, and Yassur Y. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol. 1992;76(5): 280–283. doi:10.1136/bjo.76.5.280
21. Shingleton BJ, Laul A, Nagao K, Wolff B, O’Donoghue M, Eagan E, Flattem N, Desai-Bartoli S. Effect of phacoemulsification on intraocular pressure in eyes with pseudoexfoliation: single-surgeon series. J Cataract Refract Surg. 2008;34(11): 1834–1841. doi:10.1016/j.jcrs.2008.07.025
22. Damji KF, Konstas AG, Liebmann JM, Hodge WG, Ziakas NG, Giannikakis S, Mintsioulis G, Merkur A, Pan Y, Ritch R. Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: A 2 year prospective study. Br J Ophthalmol. 2006;90: 1014–1018. doi:10.1136/
23. bjo.2006.091447
24. Pohjalainen T, Vesti E, Ulusitalo RJ, Laatikainen L. Intraocular pressure after phacoemulsification and intraocular lens implantation in nonglaucomatous eyes with and without exfoliation. J Cataract Refract Surg. 2001;27: 426–431. doi:10.1016/s0886-3350(00)00691-x
25. Rao A. Diurnal curve after phacoemulsification in patients with pseudoexfoliation syndrome and cataract. Semin Ophthalmol. 2012;27(1-2): 1–5. doi:10.3109/08820538.2011.626356
26. Shingleton BJ, Heltzer J, O’Donoghue MW. Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg. 2003;29: 1080–1086. doi:10.1016/s0886-3350(02)01993-4
27. Shingleton BJ, Gamell LS, O’Donoghue MW, Baylus SL, King R. Long-term changes in intraocular pressure after clear corneal phacoemulsification: Normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg. 1999;25: 885–890. doi:10.1016/s0886-3350(99)00107-8
28. Akinci A, Batman C, Zilelioglu O. Phacoemulsification in pseudoexfoliation syndrome. Ophthalmologica. 2008;222(2): 112–116. doi:10.1159/000112628
29. Belovay GW, Varma DK, Ahmed II. Cataract surgery in pseudoexfoliation syndrome. Curr Opin Ophthalmol. 2010;21: 25–34. doi:10.1097/ICU.0b013e328332f814
30. Cimetta DJ, Cimetta AC. Intraocular pressure changes after clear corneal phacoemulsification in nonglaucomatous pseudoexfoliation syndrome. Eur J Ophthalmol. 2008;18: 77–81. doi:10.1177/112067210801800113
31. Shingleton BJ, Crandall AS, Ahmed II. Pseudoexfoliation and the cataract surgeon: Preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses. J Cataract Refract Surg. 2009;35: 1101–1120. doi:10.1016/j.jcrs.2009.03.011
32. Merkur A, Damji KF, Mintsioulis G, Hodge WG. Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoliation syndrome. J Cataract Refract Surg. 2001;27: 528–532. doi:10.1016/s0886-3350(00)00753-7
33. Sarda V, Rohart C, Fajnkuchen F, Nghiem Buffet S, Streho M, Chaine G. Pseudoexfoliation syndrome and phacoemulsification: comparative study with a control population. J Fr Ophtalmol. 2010;33(5): 319–326. doi:10.1016/j.jfo.2010.03.016
34. Drance S. The significance of Diurnal tension variations in normal and glaucomatous eyes. Arch ophthalmol. 1960;64: 494–501.
35. R. Morreale Bubella, D. Morreale Bubella. Large diurnal variation of intraocular pressure in open angle glaucoma in subjects with type a behaviour pattern. Journal of Eye and Ophthalmology. 2014; 2055–2408. doi:10.7243/2055-2408-1-4
36. Франковска-Герлак М.З., Соколовская Т.В., Брижак П.Е., Чубарь В.С. Различные типы суточных тонометрических кривых у пациентов с катарактой и глазными проявлениями псевдоэксфолиативного синдрома. Офтальмохирургия. 2015;1: 12–16. [Frankovska-Gerlak MZ, Sokolovskaya TV, Brizhak PE, CHubar’ VS. Razlichnye tipy sutochnyh tonometricheskih krivyh u pacientov s kataraktoj i glaznymi proyavleniyami psevdoeksfoliativnogo sindroma. Oftal’mohirurgiya. 2015;1: 12–16. (In Russ.)]
Fyodorov Journal of Ophthalmic Surgery. 2020; : 24-30
Comparative assessment of daily curves in patients with cataract associated with pseudoexfoliation syndrome (PEX) before and after phacoemulsification with IOL implantation
https://doi.org/10.25276/0235-4160-2020-3-24-30Abstract
Purpose. To perform a comparative analysis of the 24-hour control of intraocular pressure (IOP) amplitudes in patients with complicated cataract associated with PEX before and after phacoemulsification of cataract.
Material and methods. The clinical study was carried out in 154 eyes of 154 patients with cataract associated with pseudoexfoliation syndrome (PEX). All patients diagnosed with cataract associated with PEX were divided into 3 groups: the group 1 included patients with normal IOP level preoperatively (n=55); the group 2 included patients with IOP ophthalmohypertension preoperatively (n=57); the group 3 included patients with primary open-angle initial glaucoma (n=42). The study of the amplitude of 24-hour fluctuations of IOP and diurnal curve of IOP before and after cataract phacoemulsification was performed. Before the PHACO+IOL the amplitude of diurnal IOP fluctuations was in the group 1: 5.22±0.49 mm Hg, and in the groups 2 and 3: 6.81±1.21 mmHg and 6.60±1.49 mm Hg, respectively.
Results. Patients of the group 1 had a significant decrease in the amplitude of diurnal IOP fluctuations by 1.27±0.93 mm Hg (p<0.001). A decrease in the amplitude of diurnal IOP fluctuations by 2.34±1.26 mm Hg (p<0.001) was noted in patients of the group 2. In the group 3 a decrease in the amplitude of diurnal IOP fluctuations by 1.15±1.14 mm Hg (p<0.001) was observed. A tendency of changes in diurnal IOP curves after surgery was revealed in all cases.
Conclusion. PHACO+IOL in patients with cataract associated with PEX allows to normalize the level, amplitude and type of diurnal IOP curve.
References
1. Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007;114: 3. doi:10.1016/j.ophtha.2006.05.075
2. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Manifest E; Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121: 48–56. doi:10.1001/archopht.121.1.48
3. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 714–720. doi:10.1001/archopht.120.6.714
4. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130: 429–440. doi:10.1016/S0002-9394(00)00538-9
5. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134: 499–512. doi:10.1016/s0002-9394(02)01659-8
6. Kass MA, Heuer DK, Higginbotham EJ. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypertensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2000;120: 701–713. doi:10.1001/archopht.120.6.701
7. Lichter PR, Musch DC, Gillespie BW. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108: 1943–1953. doi:10.1016/s0161-6420(01)00873-9
8. Krause U, Alanko HI Karna. Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol. 1988;184: 120–122. doi:10.1111/j.1755-3768.1988.tb02642.x
9. Schlötzer-Schrehardt UM, Naumann GOH. Ocular and systemic pseudoexfoliation syndrome. Am J of Ophthalmol. 2006;141: 921–937. doi:10.1016/j.ajo.2006.01.047
10. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45: 265–315. doi:10.1016/s0039-6257(00)00196-x
11. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22: 253–275.
12. Jeng S, Karger R, Hodge D, Burke J, Johnson D, Good M. The risk of glaucoma in pseudoexfoliation syndrome. J Glaucoma. 2007;16: 117–121. doi:10.1097/01.ijg.0000243470.13343.8b
13. Brengtsson B, Heiji A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2005;243: 513–518. doi:10.1007/s00417-004-1103-8
14. Altintaş O, Yüksel N, Karabaş VL, Qağlar Y. Diurnal intraocular pressure variation in pseudoexfoliation syndrome. Eur J Ophthalmol. 2004;14: 495–500.
15. Vesti E, Kivel ÄT. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19: 345–368. doi:10.1016/s1350-9462(99)00019-1
16. Prince AM, Ritch R. Clinical signs of exfoliations syndrome. Ophthalmology. 1986;93: 803–807. doi:10.1016/s0161-6420(86)33664-9
17. Kim KS, Kim JM, Park KH, Choi CY, Chang HR. The effect of cataract surgery on diurnal intraocular pressure fluctuation. J Glaucoma. 2009;18: 399–402. doi:10.1097/IJG.0b013e3181879e89
18. Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115: 182–185. doi:10.1001/archopht.1997.01100150184006
19. Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye (Lond). 2000;14: 73–77. doi:10.1038/eye.2000.16
20. David R, Zangwill L, Briscoe D, Dagan M, Yagev R, and Yassur Y. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol. 1992;76(5): 280–283. doi:10.1136/bjo.76.5.280
21. Shingleton BJ, Laul A, Nagao K, Wolff B, O’Donoghue M, Eagan E, Flattem N, Desai-Bartoli S. Effect of phacoemulsification on intraocular pressure in eyes with pseudoexfoliation: single-surgeon series. J Cataract Refract Surg. 2008;34(11): 1834–1841. doi:10.1016/j.jcrs.2008.07.025
22. Damji KF, Konstas AG, Liebmann JM, Hodge WG, Ziakas NG, Giannikakis S, Mintsioulis G, Merkur A, Pan Y, Ritch R. Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: A 2 year prospective study. Br J Ophthalmol. 2006;90: 1014–1018. doi:10.1136/
23. bjo.2006.091447
24. Pohjalainen T, Vesti E, Ulusitalo RJ, Laatikainen L. Intraocular pressure after phacoemulsification and intraocular lens implantation in nonglaucomatous eyes with and without exfoliation. J Cataract Refract Surg. 2001;27: 426–431. doi:10.1016/s0886-3350(00)00691-x
25. Rao A. Diurnal curve after phacoemulsification in patients with pseudoexfoliation syndrome and cataract. Semin Ophthalmol. 2012;27(1-2): 1–5. doi:10.3109/08820538.2011.626356
26. Shingleton BJ, Heltzer J, O’Donoghue MW. Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg. 2003;29: 1080–1086. doi:10.1016/s0886-3350(02)01993-4
27. Shingleton BJ, Gamell LS, O’Donoghue MW, Baylus SL, King R. Long-term changes in intraocular pressure after clear corneal phacoemulsification: Normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg. 1999;25: 885–890. doi:10.1016/s0886-3350(99)00107-8
28. Akinci A, Batman C, Zilelioglu O. Phacoemulsification in pseudoexfoliation syndrome. Ophthalmologica. 2008;222(2): 112–116. doi:10.1159/000112628
29. Belovay GW, Varma DK, Ahmed II. Cataract surgery in pseudoexfoliation syndrome. Curr Opin Ophthalmol. 2010;21: 25–34. doi:10.1097/ICU.0b013e328332f814
30. Cimetta DJ, Cimetta AC. Intraocular pressure changes after clear corneal phacoemulsification in nonglaucomatous pseudoexfoliation syndrome. Eur J Ophthalmol. 2008;18: 77–81. doi:10.1177/112067210801800113
31. Shingleton BJ, Crandall AS, Ahmed II. Pseudoexfoliation and the cataract surgeon: Preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses. J Cataract Refract Surg. 2009;35: 1101–1120. doi:10.1016/j.jcrs.2009.03.011
32. Merkur A, Damji KF, Mintsioulis G, Hodge WG. Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoliation syndrome. J Cataract Refract Surg. 2001;27: 528–532. doi:10.1016/s0886-3350(00)00753-7
33. Sarda V, Rohart C, Fajnkuchen F, Nghiem Buffet S, Streho M, Chaine G. Pseudoexfoliation syndrome and phacoemulsification: comparative study with a control population. J Fr Ophtalmol. 2010;33(5): 319–326. doi:10.1016/j.jfo.2010.03.016
34. Drance S. The significance of Diurnal tension variations in normal and glaucomatous eyes. Arch ophthalmol. 1960;64: 494–501.
35. R. Morreale Bubella, D. Morreale Bubella. Large diurnal variation of intraocular pressure in open angle glaucoma in subjects with type a behaviour pattern. Journal of Eye and Ophthalmology. 2014; 2055–2408. doi:10.7243/2055-2408-1-4
36. Frankovska-Gerlak M.Z., Sokolovskaya T.V., Brizhak P.E., Chubar' V.S. Razlichnye tipy sutochnykh tonometricheskikh krivykh u patsientov s kataraktoi i glaznymi proyavleniyami psevdoeksfoliativnogo sindroma. Oftal'mokhirurgiya. 2015;1: 12–16. [Frankovska-Gerlak MZ, Sokolovskaya TV, Brizhak PE, CHubar’ VS. Razlichnye tipy sutochnyh tonometricheskih krivyh u pacientov s kataraktoj i glaznymi proyavleniyami psevdoeksfoliativnogo sindroma. Oftal’mohirurgiya. 2015;1: 12–16. (In Russ.)]
